Sandra Silberman

Sandra Silberman

No open positions remaining
71 year
Health Technology
Consumer Services
Health Services

Profile

Sandra Leta Silberman worked as Senior Director-Clinical Research at Novartis Corp.
from 2000 to 2004.
Served as Vice President at Eisai Medical Research, Inc. from 2004 to 2006.
Held the position of Chief Medical Officer at Scorpius Holdings, Inc. Worked as Chief Medical Officer at CNS Pharmaceuticals, Inc. from 2017 to 2026.
Worked as Chief Medical Officer-New Products at Moleculin Biotech, Inc. from 2017 to 2024.
Education includes a doctorate from Weill Cornell Medical College, a doctorate from The Johns Hopkins University School of Medicine, and an undergraduate degree from Zanvyl Krieger School of Arts & Sciences.

Former positions of Sandra Silberman

CompaniesPositionEnd
CNS PHARMACEUTICALS, INC. Chief Tech/Sci/R&D Officer 27/02/2026
MOLECULIN BIOTECH, INC. Chief Tech/Sci/R&D Officer 01/12/2024
Eisai Medical Research, Inc.
Corporate Officer/Principal -
Chief Tech/Sci/R&D Officer -
SCORPIUS HOLDINGS, INC. Chief Tech/Sci/R&D Officer -
See the detail of Sandra Silberman's experience

Training of Sandra Silberman

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

34

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Health Technology

Health Technology

Eisai Medical Research, Inc.

Health Services

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Sandra Silberman